Dr Maya Latimer is a senior Consultant Haematologist at the Canberra Region Cancer Centre, CRCC, the Canberra Hospital, ACT and laboratory haematologist with ACT Pathology. She is currently deputy director of the department of haematology. She graduated from medical school on a full Australian merit scholarship at the University of Adelaide. She completed her haematology advanced training at the Canberra Hospital with a fellowship through Australian National University ANU, and a number of observerships at the Lymphoma and Leukaemia units of the MD Anderson Cancer Centre, MDACC in Houston, Texas, USA. She is the current chair of the ACT Health Lymphoma multi-disciplinary team meeting (MDT) as well as the co-chair of the Leukaemia Interest Group (LIG). She is also co-supervisor for the cytogenetics and molecular genomics laboratory, ACT Pathology. She is active in the Australasian Leukaemia and Lymphoma group, ALLG, participating in the CLL, lymphoma, myeloma, CML and myeloproliferative neoplasm subgroups. Her clinical and research interests include lymphoma, leukaemia, myeloma and cytogenomics. She is also a member of the Australian Lymphoma Alliance. She is a member of the Cancer Council of Australia eviQ national reference committee. She is active in local and international clinical trials and has been principal investigator for CLL, lymphoma, acute leukaemia and CML trials within the unit as well as sub-investigator in aggressive lymphoma, myeloma, acute leukaemia trials and deep vein thrombosis, DVT trials. She is also the local coordinator of advanced training for haematology and the coordinator of advanced training, CJCT with the RACP/RCPA Australasia since 2021.